Charles Schwab’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-216,524
| Closed | -$10.4M | – | 3425 |
|
|
2020
Q1 | $10.4M | Buy |
216,524
+1,835
| +0.9% | +$88.1K | 0.01% | 1428 |
|
|
2019
Q4 | $10.1M | Buy |
214,689
+6,953
| +3% | +$326K | 0.01% | 1665 |
|
|
2019
Q3 | $4.91M | Buy |
207,736
+132,216
| +175% | +$3.13M | ﹤0.01% | 1964 |
|
|
2019
Q2 | $2.27M | Buy |
75,520
+27,519
| +57% | +$828K | ﹤0.01% | 2330 |
|
|
2019
Q1 | $1.08M | Buy |
48,001
+9,491
| +25% | +$213K | ﹤0.01% | 2528 |
|
|
2018
Q4 | $701K | Buy |
38,510
+7,300
| +23% | +$133K | ﹤0.01% | 2649 |
|
|
2018
Q3 | $565K | Buy |
31,210
+7,610
| +32% | +$138K | ﹤0.01% | 2795 |
|
|
2018
Q2 | $235K | Sell |
23,600
-9,200
| -28% | -$91.6K | ﹤0.01% | 3041 |
|
|
2018
Q1 | $175K | Buy |
32,800
+11,000
| +50% | +$58.7K | ﹤0.01% | 3009 |
|
|
2017
Q4 | $186K | Hold |
21,800
| – | – | ﹤0.01% | 2990 |
|
|
2017
Q3 | $319K | Hold |
21,800
| – | – | ﹤0.01% | 2853 |
|
|
2017
Q2 | $409K | Buy |
21,800
+9,000
| +70% | +$169K | ﹤0.01% | 2760 |
|
|
2017
Q1 | $273K | Hold |
12,800
| – | – | ﹤0.01% | 2849 |
|
|
2016
Q4 | $195K | Buy |
+12,800
| New | +$195K | ﹤0.01% | 2968 |
|